Restricted accessLetterFirst published online 2024-09
Fatal Escitalopram-Induced Leukocytoclastic Vasculitis Clinically Simulating Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: Digging Deeper into an Uncommon Presentation
OrtonneN, Valeyrie-AllanoreL, Bastuji-GarinS, et al.Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: A morphological and phenotypical study. Br J Dermatol, 2015; 173(1):50–58.
2.
WalshS, Diaz-CanoS, HigginsE, et al.Drug reaction with eosinophilia and systemic symptoms: Is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases. Br J Dermatol, 2013; 168(2):391–401.
3.
BaigrieD, GoyalA, CraneJS. Leukocytoclastic vasculitis. In StatPearls. Treasure Island, FL: StatPearls Publishing, 2022.
4.
Flores-SuárezLF, Vega-MemijeME, Chanussot-DeprezC. Cutaneous vasculitis during selective serotonin reuptake inhibitor therapy. Am J Med, 2006; 119(10):e1–e3.
5.
HolderSM ten, JoyMS, FalkRJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother, 2002; 36(1):130–147.
6.
RivasS, PandyaAG, DominguezAR. Drug-Induced vasculitis. In: Cutaneous Drug Eruptions: Diagnosis, Histopathology and Therapy. Springer-Verlag. London Ltd; 2015:77–85; doi: 10.1007/978-1-4471-6729-7_8
